Subject to Regulatory Approvals, This Agreement Will Give Selected Generic Manufacturers ... - Latest Tweet by World Health Organization

Subject to regulatory approvals, this agreement will give selected generic manufacturers the opportunity to develop, manufacture & supply generic versions of CAB-LA, in 90 low- & middle-income countries. It's a 🔑 step to support long-term access to this #HIV prevention option. pic.twitter.com/SqRbRus1Vf— World Health Organization (WHO) (@WHO) July 29, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)